CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea
Sung Hee Choi, Tae Jung Oh, Hak Chul Jang
Diabetes Metab J. 2017;41(3):170-178.   Published online May 11, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.3.170

Excel Download

Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea
Diabetes & Metabolism Journal. 2017;41(3):170   Crossref logo
Link1 Link2 Link3

Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy
Journal of Diabetes and its Complications. 2015;29(8):1266-1271   Crossref logo
Link1 Link2

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
Diabetes Therapy. 2016;7(4):825-845   Crossref logo
Link1 Link2 Link3

Abstract #798656: Real Life Experience of Hydroxychloroquine in Type-2 Diabetes Patients Uncontrolled on a Combination of Metformin and Sulfonylurea for its Glycemic, Anti-Lipid and Anti-Inflammatory Parameters
Endocrine Practice. 2020;26:96-97   Crossref logo
Link1 Link2

PDB137 - COMPARISON OF ORAL ANTIDIABETIC DRUGS AS ADD-ON TREATMENTS IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON METFORMIN: A NETWORK META-ANALYSIS
Value in Health. 2018;21:S141   Crossref logo
Link1 Link2

Triple Therapy in Type 2 Diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients
Yearbook of Medicine. 2007;2007:468-471   Crossref logo
Link1 Link2

Triple Therapy in Type 2 Diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients
Yearbook of Endocrinology. 2007;2007:66-69   Crossref logo
Link1 Link2

Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes
Journal of Diabetes and its Complications. 2003;17(4):211-217   Crossref logo
Link1 Link2

Improved Glycemic Control with Insulin Glargine Versus Pioglitazone as Add-On Therapy to Sulfonylurea or Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
Endocrine Practice. 2010;16(4):588-599   Crossref logo
Link1 Link2 Link3

Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy
Diabetes Therapy. 2015;6(4):495-507   Crossref logo
Link1 Link2 Link3 Link4